BIAFW BIOAFFINITY TECHNOLOGIES INC
Follow*W EXP 09/07/202 (warrant or right), issuer CIK 1712762
5 managers (5 13F filers) reported a position in BIAFW shares at 2025-03-31, 343,475 shares in all. 0 filers opened a position and 1 filer sold out during the quarter.
- Managers
- 5
- 13F filers
- 5
- New
- 0
- Added
- 1
- Reduced
- 2
- Sold out
- 1
- Shares held by filers
- 343,475
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q1 2025
Filers in the available 13F reports with a share position at 2025-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 204,082 | $38.8K | <0.01% | 0 | 13F-HRTimeline |
| CLEAR STREET LLC | 55,122 | $10.5K | <0.01% | -11 | 13F-HRTimeline |
| UBS Group AGin group UBS Group AG | 48,283 | $9.17K | <0.01% | +47,618 | 13F-HRTimelineGroup |
| CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC | 35,988 | $6.83K | <0.01% | -14,257 | 13F-HRTimelineGroup |
| CONCOURSE FINANCIAL GROUP SECURITIES, I… | 0 | $0 | 0 | 13F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios. |